Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Braz. j. microbiol ; 46(4): 1111-1118, Oct.-Dec. 2015. tab, graf
Article in English | LILACS | ID: lil-769642

ABSTRACT

Abstract In the present work, twelve bacilli were isolated from four different regions of human skin from Bela population of Nagpur district, India. The isolated bacilli were identified by their morphological, cultural and biochemical characteristics. Seven isolates were Gram negative rods, out of which five were belong to genus Pseudomonas. Three among the five Gram positive isolates were identified as Dermabactor and the remaining two Bacillus. Their antimicrobial susceptibility profile was determined by Kirby-Bauer disc diffusion method. The isolates showed resistance to several currently used broad-spectrum antibiotics. The Dermabactor genus was resistant to vancomycin, although it was earlier reported to be susceptible. Imipenem was found to be the most effective antibiotic for Pseudomonas while nalidixic acid, ampicillin and tetracycline were ineffective. Isolates of Bacillus displayed resistance to the extended spectrum antibiotics cephalosporin and ceftazidime. Imipenem, carbenicillin and ticarcillin were found to be the most effective antibiotics as all the investigated isolates were susceptible to them. Antibiotic resistance may be due to the overuse or misuse of antibiotics during the treatment, or following constant exposure to antibiotic-containing cosmetic formulations.


Subject(s)
Adolescent/classification , Adolescent/drug effects , Adolescent/genetics , Adolescent/isolation & purification , Adolescent/microbiology , Adolescent/pharmacology , Adult/classification , Adult/drug effects , Adult/genetics , Adult/isolation & purification , Adult/microbiology , Adult/pharmacology , Anti-Bacterial Agents/classification , Anti-Bacterial Agents/drug effects , Anti-Bacterial Agents/genetics , Anti-Bacterial Agents/isolation & purification , Anti-Bacterial Agents/microbiology , Anti-Bacterial Agents/pharmacology , Bacillus/classification , Bacillus/drug effects , Bacillus/genetics , Bacillus/isolation & purification , Bacillus/microbiology , Bacillus/pharmacology , Female/classification , Female/drug effects , Female/genetics , Female/isolation & purification , Female/microbiology , Female/pharmacology , Healthy Volunteers/classification , Healthy Volunteers/drug effects , Healthy Volunteers/genetics , Healthy Volunteers/isolation & purification , Healthy Volunteers/microbiology , Healthy Volunteers/pharmacology , Humans/classification , Humans/drug effects , Humans/genetics , Humans/isolation & purification , Humans/microbiology , Humans/pharmacology , Male/classification , Male/drug effects , Male/genetics , Male/isolation & purification , Male/microbiology , Male/pharmacology , Microbial Sensitivity Tests/classification , Microbial Sensitivity Tests/drug effects , Microbial Sensitivity Tests/genetics , Microbial Sensitivity Tests/isolation & purification , Microbial Sensitivity Tests/microbiology , Microbial Sensitivity Tests/pharmacology , Middle Aged/classification , Middle Aged/drug effects , Middle Aged/genetics , Middle Aged/isolation & purification , Middle Aged/microbiology , Middle Aged/pharmacology , Skin/classification , Skin/drug effects , Skin/genetics , Skin/isolation & purification , Skin/microbiology , Skin/pharmacology , Young Adult/classification , Young Adult/drug effects , Young Adult/genetics , Young Adult/isolation & purification , Young Adult/microbiology , Young Adult/pharmacology
2.
Braz. j. microbiol ; 46(4): 943-944, Oct.-Dec. 2015.
Article in English | LILACS | ID: lil-769657

ABSTRACT

The bacterium, Inquilinus limosus, with its remarkable antimicrobial multiresistant profile, has increasingly been isolated in cystic fibrosis patients. We report draft genome sequence of a strain MP06, which is of considerable interest in elucidating the associated mechanisms of antibiotic resistance in this bacterium and for an insight about its persistence in airways of these patients.


Subject(s)
Anti-Bacterial Agents/drug effects , Anti-Bacterial Agents/genetics , Anti-Bacterial Agents/microbiology , Anti-Bacterial Agents/pharmacology , Base Sequence/drug effects , Base Sequence/genetics , Base Sequence/microbiology , Base Sequence/pharmacology , Drug Resistance, Multiple, Bacterial/drug effects , Drug Resistance, Multiple, Bacterial/genetics , Drug Resistance, Multiple, Bacterial/microbiology , Drug Resistance, Multiple, Bacterial/pharmacology , Genome, Bacterial/drug effects , Genome, Bacterial/genetics , Genome, Bacterial/microbiology , Genome, Bacterial/pharmacology , Gram-Negative Bacterial Infections/drug effects , Gram-Negative Bacterial Infections/genetics , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/pharmacology , Humans/drug effects , Humans/genetics , Humans/microbiology , Humans/pharmacology , Molecular Sequence Data/drug effects , Molecular Sequence Data/genetics , Molecular Sequence Data/microbiology , Molecular Sequence Data/pharmacology , Rhodospirillaceae/drug effects , Rhodospirillaceae/genetics , Rhodospirillaceae/microbiology , Rhodospirillaceae/pharmacology
3.
Braz. j. microbiol ; 46(4): 1119-1124, Oct.-Dec. 2015. tab
Article in English | LILACS | ID: lil-769658

ABSTRACT

Abstract Acinetobacter baumannii is a frequently isolated etiologic agent of nosocomial infections, especially in intensive care units. With the increase in multi-drug resistance of A. baumannii isolates, finding appropriate treatment alternatives for infections caused by these bacteria has become more difficult, and available alternate treatments include the use of older antibiotics such as colistin or a combination of antibiotics. The current study aimed to evaluate the in vitro efficacy of various antibiotic combinations against multi-drug resistant A. baumannii strains. Thirty multi-drug and carbapenem resistant A. baumannii strains isolated at the Ankara Training and Research Hospital between June 2011 and June 2012 were used in the study. Antibiotic susceptibility tests and species-level identification were performed using conventional methods and the VITEK 2 system. The effects of meropenem, ciprofloxacin, amikacin, tigecycline, and colistin alone and in combination with sulbactam against the isolates were studied using Etest (bioMérieux) in Mueller-Hinton agar medium. Fractional inhibitory concentration index (FIC) was used to determine the efficacy of the various combinations. While all combinations showed a predominant indifferent effect, a synergistic effect was also observed in 4 of the 5 combinations. Synergy was demonstrated in 43% of the isolates with the meropenem-sulbactam combination, in 27% of the isolates with tigecycline-sulbactam, and in 17% of the isolates with colistin-sulbactam and amikacin-sulbactam. No synergy was detected with the sulbactam-ciprofloxacin combination and antagonism was detected only in the sulbactam-colistin combination (6.66% of the isolates). Antibiotic combinations can be used as an alternative treatment approach in multi-drug resistant A. baumannii infections.


Subject(s)
Acinetobacter Infections/drug effects , Acinetobacter Infections/growth & development , Acinetobacter Infections/microbiology , Acinetobacter Infections/pharmacology , Acinetobacter baumannii/drug effects , Acinetobacter baumannii/growth & development , Acinetobacter baumannii/microbiology , Acinetobacter baumannii/pharmacology , Anti-Bacterial Agents/drug effects , Anti-Bacterial Agents/growth & development , Anti-Bacterial Agents/microbiology , Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple, Bacterial/drug effects , Drug Resistance, Multiple, Bacterial/growth & development , Drug Resistance, Multiple, Bacterial/microbiology , Drug Resistance, Multiple, Bacterial/pharmacology , Drug Synergism/drug effects , Drug Synergism/growth & development , Drug Synergism/microbiology , Drug Synergism/pharmacology , Humans/drug effects , Humans/growth & development , Humans/microbiology , Humans/pharmacology , Microbial Sensitivity Tests/drug effects , Microbial Sensitivity Tests/growth & development , Microbial Sensitivity Tests/microbiology , Microbial Sensitivity Tests/pharmacology , Sulbactam/drug effects , Sulbactam/growth & development , Sulbactam/microbiology , Sulbactam/pharmacology
4.
Braz. j. pharm. sci ; 45(3): 551-557, July-Sept. 2009. ilus, tab
Article in English | LILACS | ID: lil-533183

ABSTRACT

The use of mouthwashes in critical patients has been a source of concern for health professionals due to the diverse range of products, causing uncertainty about which is the most indicated. This study aimed to assess the susceptibility of Staphylococcus spp. isolated in the saliva of individuals from the community and patients in Intensive Care Units (ICU) as to antiseptic mouthwashes. The following oral antiseptics were assessed: cetylpyridinium chloride solution, Listerine® and Neen®. Calcium alginate swab was used for saliva collection to isolate Staphylococcus spp. Microbiological processing involved growth, isolation, strain identification and determination of MID (maximum inhibitory dilution). MID was considered the greatest dilution that completely inhibited the strains. The products efficacy was analyzed by a two-factor ANOVA repeated measures and by Bonferroni adjustments in multiple comparisons, considering a significance level of α=0.05. In total, 80 strains of Staphylococcus spp. were isolated, 40 from ICU patients and 40 from community individuals. MID results revealed that cetylpyridinium chloride solution presented better results in comparison to other products, that is, 39 (97.5 percent) strains from hospital patients with MID 1:128, and 37 (92.5 percent) of individuals from the community had MID 1:64. Neen® inhibited all strains in both groups at a dilution from 1:2 to 1:4. Listerine® presented the worst MID results, 65 percent of the strains from individuals from the community and 10 percent of hospital strains were not inhibited at a dilution of 1:2.


O uso de antissépticos bucais tem sido uma das preocupações dos profissionais de saúde considerando a diversidade de produtos, o que traz a insegurança sobre qual é o mais adequado. Objetivou-se avaliar a suscetibilidade de Staphylococcus spp. isolado da saliva de indivíduos adultos da comunidade e do hospital frente a antissépticos bucais. Os antissépticos avaliados foram: solução de Cloreto de Cetilpiridínio, Listerine® e Neen®. Na coleta de saliva para o isolamento do Staphylococcus spp. utilizou-se o swab de alginato de cálcio. O processamento microbiológico envolveu o crescimento, isolamento, identificação das cepas, determinação da DIM. Foi considerada DIM a maior diluição que inibiu completamente as cepas. A eficácia dos produtos foi avaliada por meio da análise de variância (ANOVA) bilateral com medidas repetidas, e pelo método de ajuste de Bonferroni nas comparações múltiplas, com um nível de significância α=0,05. Totalizou-se 80 cepas de Staphylococcus spp. sendo 40 isoladas de pacientes da UTI e 40 de indivíduos da comunidade. Comparando os resultados é possível verificar que a solução de cloreto de cetilpiridínio apresentou melhores resultados em relação aos demais produtos, ou seja, 39 (97,5 por cento) das cepas hospitalares DIM 1:128 e da comunidade 37 (92,5 por cento) DIM 1:64. Para Neen® nos dois grupos a DIM foi de 1:2 e 1:4. Listerine® apresentou o pior resultado em termos da DIM, sendo que 65 por cento das cepas da comunidade e 10 por cento hospitalar não foram inibidas na diluição 1:2.


Subject(s)
Humans , Male , Female , Adult , Analysis of Variance , Humans/microbiology , Mouthwashes , Inpatients/statistics & numerical data , Staphylococcus , Saliva/microbiology , Oral Health , Oral Hygiene , Outcome Assessment, Health Care
SELECTION OF CITATIONS
SEARCH DETAIL